US loss of exclusivity · Oncology

Calquence

AstraZeneca

2032US generics from
2025Today: 20262037
2025 worldwide sales
$3.5B
Date basis
Patent-expiry estimate
US generics
Filed with the FDA
Medicare price
−40% from 2027
Pharma Patent Cliff by readouts.io Data checked 24 October 2026 · Full Calquence timeline →